Referências Científicas Para Pacientes | Ellansé®
Ir para a seção de pacientes
Ir para a seção de médicos
PT
Deutsch English Español Italiano Nederlands Português Português do Brasil Tiếng Việt polski Ελληνικα Русский العربية فارسی 日本語 简体中文 한국어 Français

Bibliografia

  1. Vleggaar D et al. Dermatological implications of skeletal ageing: a focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol 2008;7:209-220.
  2. Coleman SR et al. The anatomy of the ageing face: volume loss and changes in 3-dimensional topography. Aesthet Surg J 2006;26(suppl 1):S4- S9.
  3. Zimbler MS et al. Anatomy and pathophysiology of facial ageing. Facial Plast Surg Clin North Am 2001;9:179-187.
  4. Murphy MR et al. The ageing face consultation. Em: Master Techniques in Facial Rejuvenation. Elsevier 2006;1-16.
  5. Le Louarn C. Botulinum toxin and the Face Recurve® concept: decreasing resting tone and muscular regeneration. Ann Chir Plast Esth 2007;52:165-176.
  6. Donofrio LM. Fat distribution: a morphologic study of the ageing face. Dermatol Surg 2000;26:1107-1111.
  7. Valenga, Baroni et al, Influência do envelhecimento na qualidade da pele da mulher branca – o papel do colagênio. Acta Cirúrgica Brasileira 2012; 27: 736- 740
  8. Marcação CE – Dossiê Técnico (Whitepaper W113.05).
  9. Nicolau PJ et al. Neocollagenesis after injection ofapolycaprolactonebaseddermalfillerina rabbit. Eur J Aesth Med Dermatol 2013;3(1):19- 26.
  10. Moers-Carpi MM et al. Polycaprolactone for the Correction of Nasolabial Folds: A 24-Month, Prospective, Randomized, Controlled Clinical Trial. Dermatol Surg 2013;39:457-463.
  11. Pitt CG. Aliphatic polyesters II The degradation of Poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivo. Biomaterials 1981;2:215-220.
  12. Varani J. Decrease collagen production in chronologically aged skin. Am J Pathol 2006;168: 1861-1868.
  13. Woodruff MA et al. The return of a forgotten polymer: polycaprolactone in the 21st century. Prog Polym Sci 2010;35(10):1217-1256.
  14. Kim et al. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler.JournalofCosmeticandLaserTherapy, 2014; Early Online: 1-3.
  15. Galadari et al. A randomized, prospective, blinded, split face, single center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. The Journal of Cosmetic Dermatology.
  16. Laeschke K. Biocompatibility of microparticles intosofttissuefillers.SeminCutanMedSurg 2004; 23(4):214-217.
  17. Morhenn VB et al. Phagocytosis of different particulatedermalfillersubstancesbyhuman macrophages and skin cells. Dermatol Surg 2002;28(6):484-490.
  18. AndersonJM.Mechanismofinflammationand infection with implanted devices. Cardiovasc Pathol 1993;2:33S-41S.
  19. Matlage BF et al. Tissue response to implanted polymers:Thesignificanceofsampleshape. J Biomed Meter Res 1976;10:391-397.
  20. NicolauPJ.Long-Lastingandpermanentfillers: Biomaterialsinfluenceoverhostresponse.Plast Reconstr Surg 2007;119:2271-2286.
  21. Ellanse Safety W310.01

Bem-vindo a

Selecione a opção que melhor o descreve.

Paciente
Médico